Cargando…
SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope
Serine incorporator 3 (SERINC3) and SERINC5 were recently identified as host intrinsic factors against human immunodeficiency virus (HIV)-1 and counteracted by HIV-1 Nef. However, whether they inhibit hepatitis B virus (HBV), which is a severe health problem worldwide, is unknown. Here, we demonstra...
Autores principales: | Liu, Yue, Wang, Hong, Zhang, Jun, Yang, Jing, Bai, Lu, Zheng, Baisong, Zheng, Tianhang, Wang, Yingchao, Li, Jianhua, Zhang, Wenyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216740/ https://www.ncbi.nlm.nih.gov/pubmed/32431673 http://dx.doi.org/10.3389/fmicb.2020.00697 |
Ejemplares similares
-
Novel monoclonal antibodies to the SERINC5 HIV-1 restriction factor detect endogenous and virion-associated SERINC5
por: Molnar, Sebastian, et al.
Publicado: (2020) -
Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity
por: Diehl, William E., et al.
Publicado: (2021) -
ATP1B3 Restricts Hepatitis B Virus Replication Via Reducing the Expression of the Envelope Proteins
por: Zhang, Jun, et al.
Publicado: (2021) -
A G-quadruplex motif in an envelope gene promoter regulates transcription and virion secretion in HBV genotype B
por: Biswas, Banhi, et al.
Publicado: (2017) -
HIV envelope tail truncation confers resistance to SERINC5 restriction
por: Haider, Tafhima, et al.
Publicado: (2021)